Astellas has been haunted by patient deaths in a previous trial for a tricky neuromuscular condition, but that hasn’t stopped the Japanese Big Pharma from
With multiple mid- and late-stage failures of its only clinical-stage compound, Corbus Pharmaceuticals is attempting to move forward with earlier-stage assets it in-licensed this summer. So the biopharma hired Takeda oncology leader Rachael Brake as chief scientific officer to lead those efforts.
Takeda s norovirus vaccine spinout, HilleVax, secures $135M crossover fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
The CRO megamerger is back as Icon snaps up PRA Health for $12B fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.